Italia markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
82,02-0,27 (-0,33%)
Alla chiusura: 03:59PM EDT
81,90 -0,12 (-0,15%)
Dopo ore: 04:12PM EDT

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
https://www.medtronic.com

Settore/iHealthcare
SettoreMedical Devices
Impiegati a tempo pieno95.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Geoffrey Straub MarthaChairman of the Board & CEO1,79MN/D1970
Ms. Karen L. ParkhillExecutive VP & CFO992,24kN/D1965
Mr. Sean M. SalmonExecutive VP & President of Cardiovascular Portfolio900,97k418,71k1965
Mr. Robert J. W. ten HoedtExecutive VP & President of Global Regions1,24M96,01k1960
Mr. Mark PloofSenior Vice President of Global Operations and Business ServicesN/DN/DN/D
Ms. Jennifer M. KirkSenior VP, Global Controller & Chief Accounting OfficerN/DN/D1975
Dr. Kenneth E. Washington Ph.D.Senior VP and Chief Technology & Innovation OfficerN/DN/D1960
Dr. Laura Mauri M.D., M.Sc.Senior VP and Chief Scientific & Medical OfficerN/DN/DN/D
Mr. Ryan WeispfenningVP & Head of Investor RelationsN/DN/DN/D
Mr. Ivan K. FongExecutive VP, General Counsel & Secretary985,57kN/D1961
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Governance aziendale

L'ISS Governance QualityScore di Medtronic plc al 1 maggio 2024 è 6. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 6; diritti degli azionisti: 6; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.